← back to search

Juan Chen

Centre for Drug Research and Development · CA
Area of research
Biomedical Engineering · Pulmonary and Respiratory Medicine
Research interest
Research interests include Nanoplatforms for cancer theranostics, Photodynamic Therapy Research Studies, Advanced biosensing and bioanalysis techniques, and Nanoparticle-Based Drug Delivery.
h-index
67
citations
19,979
works
759
NIH funding
primary concept
email

Recent publications

A Membrane Fluidization Strategy Significantly Boosts Photodynamic Therapy and Antitumor Immunity of Porphyrin-Lipid Nanoparticles.
2026cited by 1position: contributordoi
Engineering Nanoemulsions to Maximize NIR-II Fluorescence and Preserve Photothermal Performance of a Novel Boron Difluoride Formazanate Dye.
2026cited by 0position: contributordoi
Engineering Nanoemulsions to Maximize NIR‐II Fluorescence and Preserve Photothermal Performance of a Novel Boron Difluoride Formazanate Dye
Angewandte Chemie 2026cited by 0position: contributordoi
Impact of Ligand Structure on Biological Activity and Photophysical Properties of NHC-Protected Au<sub>13</sub> Nanoclusters.
2025cited by 17position: contributordoi
Diving into Unknown Waters: Water-Soluble Clickable Au<sub>13</sub> Nanoclusters Protected with N-Heterocyclic Carbenes for Bio-Medical Applications.
2025cited by 16position: contributordoi
Lipid-siRNA Organization Modulates the Intracellular Dynamics of Lipid Nanoparticles.
2025cited by 15position: contributordoi
Next generation of porphysomes for improved photodynamic therapy applications.
2025cited by 10position: contributordoi
Cutaneous photosensitivity of phototheranostic porphyrin-lipid nanoparticles.
2025cited by 4position: contributordoi
Atomically-precise Au&lt;sub&gt;22&lt;/sub&gt;(Lys-Cys-Lys)&lt;sub&gt;16&lt;/sub&gt; nanoclusters for radiation sensitization.
2025cited by 3position: contributordoi
Photodynamic therapy of cancer-associated infections.
2025cited by 1position: contributordoi
Theranostic porphyrin nanoparticles identify atherosclerosis via multimodal imaging and elicit atheroprotective effects.
2025cited by 1position: contributordoi
Porphyrin-based nanotechnology: a minimally invasive approach for drug delivery and cholesteatoma treatment.
2025cited by 0position: contributordoi
Fabricating and Labeling Microbubbles with Fluorescent and Radioactive Tracers.
2025cited by 0position: contributordoi
Radiopharmaceutical kit to prepare Copper-64 labelled porphyrin-lipid nanoparticles for radiotracer imaging studies in cancer patients.
2025cited by 0position: contributordoi
Co-training with Soft-Hard Pseudo-Labels for Semi-supervised Liver Tumor Segmentation
Lecture notes in computer science 2025cited by 0position: lastdoi
Effects of synbiotics surpass probiotics alone in improving type 2 diabetes mellitus: A randomized, double-blind, placebo-controlled trial
Clinical Nutrition 2024cited by 20position: middledoi
Quantitative Pharmacokinetics Reveal Impact of Lipid Composition on Microbubble and Nanoprogeny Shell Fate.
2024cited by 9position: contributordoi
Nanoparticle-mediated Photodynamic Therapy as a Method to Ablate Oral Cavity Squamous Cell Carcinoma in Preclinical Models.
2024cited by 8position: contributordoi
Structural Effect of Rhenium- and Iridium-Complex Liposome Composition on Their Selectivity for Antimicrobial Photodynamic Therapy.
2024cited by 3position: contributordoi
Figure S1 from Nanoparticle-mediated Photodynamic Therapy as a Method to Ablate Oral Cavity Squamous Cell Carcinoma in Preclinical Models
2024cited by 0position: contributordoi
FIGURE 3 from Nanoparticle-mediated Photodynamic Therapy as a Method to Ablate Oral Cavity Squamous Cell Carcinoma in Preclinical Models
2024cited by 0position: contributordoi
Data from Nanoparticle-mediated Photodynamic Therapy as a Method to Ablate Oral Cavity Squamous Cell Carcinoma in Preclinical Models
2024cited by 0position: contributordoi
Figure S9 from Nanoparticle-mediated Photodynamic Therapy as a Method to Ablate Oral Cavity Squamous Cell Carcinoma in Preclinical Models
2024cited by 0position: contributordoi
Figure S7 from Nanoparticle-mediated Photodynamic Therapy as a Method to Ablate Oral Cavity Squamous Cell Carcinoma in Preclinical Models
2024cited by 0position: contributordoi
FIGURE 3 from Nanoparticle-mediated Photodynamic Therapy as a Method to Ablate Oral Cavity Squamous Cell Carcinoma in Preclinical Models
2024cited by 0position: contributordoi
Supplementary Methods from Nanoparticle-mediated Photodynamic Therapy as a Method to Ablate Oral Cavity Squamous Cell Carcinoma in Preclinical Models
2024cited by 0position: contributordoi
Figure S9 from Nanoparticle-mediated Photodynamic Therapy as a Method to Ablate Oral Cavity Squamous Cell Carcinoma in Preclinical Models
2024cited by 0position: contributordoi
Supplementary Tables from Nanoparticle-mediated Photodynamic Therapy as a Method to Ablate Oral Cavity Squamous Cell Carcinoma in Preclinical Models
2024cited by 0position: contributordoi
FIGURE 6 from Nanoparticle-mediated Photodynamic Therapy as a Method to Ablate Oral Cavity Squamous Cell Carcinoma in Preclinical Models
2024cited by 0position: contributordoi
Figure S5 from Nanoparticle-mediated Photodynamic Therapy as a Method to Ablate Oral Cavity Squamous Cell Carcinoma in Preclinical Models
2024cited by 0position: contributordoi

Grants

No grants ingested yet.

Frequent collaborators

Gang Zheng · Western Sydney University75 papers (2014–2026) · 64 papers (2019–2026) · 45 papers (2021–2026)Robert Weersink · University of Toronto36 papers (2024–2025)Michael S. Valic · 36 papers (2024–2025)Sharon Tzelnick · Tel Aviv University35 papers (2024–2024)Jonathan C. Irish · Princess Margaret Cancer Centre35 papers (2024–2024)Harley H.L. Chan · 35 papers (2024–2024)Tiziana Mondello · University of Padua35 papers (2024–2024)Catriona M. Douglas · NHS Greater Glasgow and Clyde35 papers (2024–2024)Abdullah El-Sayes · 35 papers (2024–2024)Michael J. Daly · University College London Hospitals NHS Foundation Trust35 papers (2024–2024)Donovan Eu · National University Hospital35 papers (2024–2024)Nidal Muhanna · Tel Aviv University35 papers (2024–2024)Mark Zheng · Princess Margaret Cancer Centre35 papers (2024–2024)Lili Ding · University Health Network35 papers (2024–2024)Jason L. Townson · 35 papers (2024–2024)Alon Pener-Tessler · University Health Network35 papers (2024–2024)Alexander Dhaliwal · McMaster University4 papers (2022–2024)Qi Zhang · Chongqing Emergency Medical Center3 papers (2020–2021)